Levodopa/Benserazide-Induced Drug Reaction with Eosinophilia and Systemic Symptom Syndrome

Abstract

Get full access to this article

View all access options for this article.

References

Anang

JBM

. Levodopa-carbidopa-related rash in Parkinson's disease: a case series. Can J Neurol Sci, 2018; 45:588–589.

Skorvamek

, Bhatia

. The skin and Parkinson's disease: review of clinical, diagnostic, and therapeutic issues. Mov Disord Clin Pract, 2017; 4:21–31.

Kardaun

, Sekula

, Valeyrie-Allanore

, et al., RegiSCAR study group. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol, 2013; 169:1071–1080.

Bougea

, Spantideas

, Katoulis

, et al.. Levodopa-induced skin disorders in patients with Parkinson disease: a systematic literature review approach. Acta Neurol Belg, 2019; 119:325–336.

Cansino-Torres

, Sandoval-Rodríguez

, Sáenz-Farret

, et al.. Allergy to carbidopa. Clin Neuropharmacol, 2018; 41:75–79.

Barbaud

, Collet

, Milpied

, et al.. A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions. Br J Dermatol, 2013; 168:555–562.